Radiation recall dermatitis and radiation pneumonitis during treatment with vemurafenib

Melanoma Research

Volumn 24, Issue 5, 2014, Pages 512-516

  Forschner, Andrea ^a   Zips, Daniel ^a   Schraml, Christina ^a   Röcken, Martin ^a   Iordanou, Eleni ^a   Leiter, Ulrike ^a   Weide, Benjamin ^a   Garbe, Claus ^a   Meier, Friedegund ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Dermatitis; Metastatic melanoma; Pneumonitis; Radiation recall; Radiotherapy; Vemurafenib

Indexed keywords

AMBROXOL; AMOXICILLIN PLUS CLAVULANIC ACID; CORTICOSTEROID; DEXAMETHASONE; PREDNISOLONE; VEMURAFENIB; ANTINEOPLASTIC AGENT; B RAF KINASE; BRAF PROTEIN, HUMAN; INDOLE DERIVATIVE; SULFONAMIDE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; FEMALE; HUMAN; MALE; MELANOMA METASTASIS; MIDDLE AGED; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIATION DOSE; RADIATION PNEUMONIA; RADIATION RECALL DERMATITIS; RADIATION RECALL PNEUMONITIS; SYSTEMIC THERAPY; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; GENETICS; LIVER; LUNG; LYMPH NODE METASTASIS; MELANOMA; MULTIMODALITY CANCER THERAPY; MUTATION; RADIATION RESPONSE; SKIN; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INDOLES; LIVER; LUNG; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; RADIATION PNEUMONITIS; RADIODERMATITIS; SKIN; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84926117146     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0000000000000078     Document Type: Article

References (32)

1. D'Angio GJ, Farber S, Madock CL. Potentiation of X-ray effects of actinomycin D. Radiology 1959;73:175-177.
2. Azria D, Magné N, Zouhair A, Castadot P, Culine S, Ychou M, et al. Radiation recall: a well recognized but neglected phenomenon. Cancer Treat Rev 2005;31:555-570.
3. Hird AE, Wilson J, Symons S, Sinclair E, Davis M, Chow E. Radiation recall dermatitis: case report and review of the literature. Curr Oncol 2008;15:53-62.
4. Ding X, Ji W, Li J, Zhang X, Wang L. Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer. Radiat Oncol 2011;6:24.
5. Reigneau M, Granel-Brocard F, Geoffrois L, Bauman AS, Tréchot P, Barbaud A, Schmutz JL. Efflorescence of scalp cysts during vemurafenib treatment following brain radiation therapy: a radiation recall dermatitis? Eur J Dermatol 2013;23:544-545.
6. Boussemart L, Boivin C, Claveau J, Tao YG, Tomasic G, Routier E, et al. Vemurafenib and radiosensitization. JAMA Dermatol 2013;149:855-857.
7. Burris HA 3rd, Hurtig J. Radiation recall with anticancer agents. Oncologist 2010;15:1227-1237.
8. Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001;59:237-245.
9. Castellano D, Hitt R, Cortés-Funes H, Romero A, Rodriguez-Peralto JL. Side effects of chemotherapy. Case 2. Radiation recall reaction induced by gemcitabine. J Clin Oncol 2000;18:695-696.
10. Castellano D, Hitt R, Ciruelos E, Cortés-Funes H, Colomer R. Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors. Ann Oncol 2003;14:783-787.
11. Cole PD, Schwartz CL, Drachtman RA, De Alarcon PA, Chen L, Trippett TM. Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report. J Clin Oncol 2009;27:1456-1461.
12. Hill AB, Tattersall SF. Recall of radiation pneumonitis after intrapleural administration of doxorubicin. Med J Aust 1983;1:39-40.
13. Ma LD, Taylor GA, Wharam MD, Wiley JM. 'Recall' pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology 1993;187:465-467.
14. Mclnerney DP, Bullimore J. Reactivation of radiation pneumonitis by adriamycin. Br J Radiol 1977;50:224-227.
15. Morkas M, Fleming D, Hahl M. Challenges in oncology. Case 2. Radiation recall associated with docetaxel. J Clin Oncol 2002;20:867-869.
16. Phillips KA, Urch M, Bishop JF. Radiation-recall dermatitis in a patient treated with paclitaxel. J Clin Oncol 1995;13:305.
17. Schwarte S, Wagner K, Karstens JH, Bremer M. Radiation recall pneumonitis induced by gemcitabine. Strahlenther Onkol 2007;183:215-217.
18. Schweitzer VG, Juillard GJ, Bajada CL, Parker RG. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer 1995;76:1069-1072.
19. Shenkier T, Gelmon K. Paclitaxel and radiation-recall dermatitis. J Clin Oncol 1994;12:439.
20. Togashi Y, Masago K, Mishima M, Fukudo M, Inui K. A case of radiation recall pneumonitis induced by erlotinib, which can be related to high plasma concentration. J Thorac Oncol 2010;5:924-925.
21. Sambade MJ, Peters EC, Thomas NE, Kaufmann WK, Kimple RJ, Shields JM. Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032. Radiother Oncol 2011;98:394-399.
22. Anker CJ, Ribas A, Grossmann AH, Chen X, Narra KK, Akerley W, et al. Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma. J Clin Oncol 2013;31:283-287.
23. Satzger I, Degen A, Asper H, Kapp A, Hauschild A, Gutzmer R. Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy. J Clin Oncol 2013;31:220-222.
24. Chang JY, Liu H, Balter P, Komaki R, Liao Z, Welsh J, et al. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol 2012;7:152.
25. Larici AR, Del Ciello A, Maggi F, Santoro SI, Meduri B, Valentini V, et al. Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer [review]. Radiographics 2011;31:771-789.
26. Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, et al. Radiation dose-volume effects in the lung [review]. Int J Radiat Oncol Biol Phys 2010;76:70-76.
27. Fontana JA. Radiation recall associated with VP-16-213 therapy. Cancer Treat Rep 1979;63:224-225.
28. Haffty BG, Vicini FA, Beitsch P, Quiet C, Keleher A, Garcia D, et al. Timing of chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Int J Radiat Oncol Biol Phys 2008;72:1441-1448.
29. Cassady JR, Richter MP, Piro AJ, Jaffe N. Radiation-adriamycin interactions: preliminary clinical observations. Cancer 1975;36:946-949.
30. Singer EA, Warren RD, Pennanen MF, Collins BT, Hayes DF. Tamoxifen-induced radiation recall dermatitis. Breast J 2004;10:170-171.
31. Seidel C, Janssen S, Karstens JH, Welte T, Morgan M, Ganser A, et al. Recall pneumonitis during systemic treatment with sunitinib. Ann Oncol 2010;21:2119-2120.
32. Niyazi M, Maihoefer C, Krause M, Rödel C, Budach W, Belka C. Radiotherapy and 'new' drugs - new side effects? [review]. Radiat Oncol 2011;6:177.